Anti-MKNK2 antibodies are used in the immunodetection of the protein MAPK interacting serine/threonine kinase 2. In humans, the canonical protein has a reported length of 465 amino acid residues and a mass of 51.9 kDa. Its subcellular localization is in the nucleus and cytoplasm. Up to 5 different isoforms have been reported for this protein. It is widely expressed across many tissue types. A member of the CAMK Ser/Thr protein kinase protein family, MKNK2 is a type of serine/threonine-protein kinase that phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. Synonyms for this target antigen include MNK2, MAP kinase-interacting serine/threonine-protein kinase 2, MAP kinase interacting serine/threonine kinase 2, MAP kinase signal-integrating kinase 2, MAPK signal-integrating kinase 2, and GPRK7. MKNK2 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. A number of MKNK2 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. In addition, ELISA is also a common application.